Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Brain regions mediating alpha3beta4 nicotinic antagonist effects of 18-MC on methamphetamine and sucrose self-administration.

Glick SD, Sell EM, Maisonneuve IM.

Eur J Pharmacol. 2008 Dec 3;599(1-3):91-5. doi: 10.1016/j.ejphar.2008.09.038.

2.

Brain regions mediating α3β4 nicotinic antagonist effects of 18-MC on nicotine self-administration.

Glick SD, Sell EM, McCallum SE, Maisonneuve IM.

Eur J Pharmacol. 2011 Nov 1;669(1-3):71-5. doi: 10.1016/j.ejphar.2011.08.001.

3.

18-Methoxycoronaridine acts in the medial habenula and/or interpeduncular nucleus to decrease morphine self-administration in rats.

Glick SD, Ramirez RL, Livi JM, Maisonneuve IM.

Eur J Pharmacol. 2006 May 10;537(1-3):94-8.

PMID:
16626688
4.

Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment.

Maisonneuve IM, Glick SD.

Pharmacol Biochem Behav. 2003 Jun;75(3):607-18.

PMID:
12895678
5.
6.

α3β4 nicotinic acetylcholine receptors in the medial habenula modulate the mesolimbic dopaminergic response to acute nicotine in vivo.

McCallum SE, Cowe MA, Lewis SW, Glick SD.

Neuropharmacology. 2012 Sep;63(3):434-40. doi: 10.1016/j.neuropharm.2012.04.015.

7.

Novel iboga alkaloid congeners block nicotinic receptors and reduce drug self-administration.

Pace CJ, Glick SD, Maisonneuve IM, He LW, Jokiel PA, Kuehne ME, Fleck MW.

Eur J Pharmacol. 2004 May 25;492(2-3):159-67.

PMID:
15178360
8.

Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration.

Glick SD, Maisonneuve IM, Kitchen BA, Fleck MW.

Eur J Pharmacol. 2002 Mar 1;438(1-2):99-105.

PMID:
11906717
9.

Attenuation of morphine withdrawal signs by intracerebral administration of 18-methoxycoronaridine.

Panchal V, Taraschenko OD, Maisonneuve IM, Glick SD.

Eur J Pharmacol. 2005 Nov 21;525(1-3):98-104.

PMID:
16289028
10.

Modulation of nicotine self-administration in rats by combination therapy with agents blocking alpha 3 beta 4 nicotinic receptors.

Glick SD, Maisonneuve IM, Kitchen BA.

Eur J Pharmacol. 2002 Jul 19;448(2-3):185-91.

PMID:
12144940
11.

18-MC reduces methamphetamine and nicotine self-administration in rats.

Glick SD, Maisonneuve IM, Dickinson HA.

Neuroreport. 2000 Jun 26;11(9):2013-5.

PMID:
10884062
12.

18-methoxycoronaridine: a potential new treatment for obesity in rats?

Taraschenko OD, Rubbinaccio HY, Maisonneuve IM, Glick SD.

Psychopharmacology (Berl). 2008 Dec;201(3):339-50. doi: 10.1007/s00213-008-1290-9.

13.

Nicotinic receptors in the habenulo-interpeduncular system are necessary for nicotine withdrawal in mice.

Salas R, Sturm R, Boulter J, De Biasi M.

J Neurosci. 2009 Mar 11;29(10):3014-8. doi: 10.1523/JNEUROSCI.4934-08.2009.

14.

Effects of 18-methoxycoronaridine on ghrelin-induced increases in sucrose intake and accumbal dopamine overflow in female rats.

McCallum SE, Taraschenko OD, Hathaway ER, Vincent MY, Glick SD.

Psychopharmacology (Berl). 2011 May;215(2):247-56. doi: 10.1007/s00213-010-2132-0.

15.

18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats.

Glick SD, Kuehne ME, Maisonneuve IM, Bandarage UK, Molinari HH.

Brain Res. 1996 May 6;719(1-2):29-35.

PMID:
8782860
16.
17.

Muscarinic, but not nicotinic, acetylcholine receptor blockade in the ventral tegmental area attenuates cue-induced sucrose-seeking.

Addy NA, Nunes EJ, Wickham RJ.

Behav Brain Res. 2015 Sep 15;291:372-6. doi: 10.1016/j.bbr.2015.05.036.

18.

Is antagonism of alpha3beta4 nicotinic receptors a strategy to reduce morphine dependence?

Taraschenko OD, Panchal V, Maisonneuve IM, Glick SD.

Eur J Pharmacol. 2005 Apr 25;513(3):207-18.

PMID:
15862802
19.

Effects of subunit selective nACh receptors on operant ethanol self-administration and relapse-like ethanol-drinking behavior.

Kuzmin A, Jerlhag E, Liljequist S, Engel J.

Psychopharmacology (Berl). 2009 Mar;203(1):99-108. doi: 10.1007/s00213-008-1375-5.

PMID:
18987848
20.

Development of novel medications for drug addiction. The legacy of an African shrub.

Glick SD, Maisonneuve IM.

Ann N Y Acad Sci. 2000;909:88-103.

PMID:
10911925
Items per page

Supplemental Content

Support Center